Sponsor content
106 result(s) found, displaying 31 to 40
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Cellular Therapies - T Cells - Brexucabtagene autoleucel, cryopreserved - T - Tecartus - Gilead Sciences Pty Ltd - Injection, intravenous infusion - Bag.
-
Cancellation by sponsorRequested by Gilead Sciences Pty Ltd
-
Cancellation by sponsorRequested by Gilead Sciences Pty Ltd
-
Designation or determinationPriority review
-
Prescription medicine registrationActive ingredients: T Cells - axicabtagene ciloleucel, cryopreserved - T - Yescarta.
-
Prescription medicine registrationActive ingredients: T Cells - Brexucabtagene autoleucel, cryopreserved - T - Tecartus.
-
Cancellation by sponsorRequested by Gilead Sciences Pty Ltd
-
Australian public assessment report (AusPar)New AusPAR for VEKLURY (remdesivir ) for the treatment of coronavirus disease 2019 in paediatric and adult patients.
-
Prescription medicine registrationActive ingredients: remdesivir.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VEKLURY remdesivir 100 mg powder for injection vial.